Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of BMN 673 and Selected Cytotoxics in Patients With Advanced Solid Tumors

NCT02049593 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT02049593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02049593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of BMN 673 and Selected Cytotoxics in Patients With Advanced Solid Tumors
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Phase 1
Overall status
Completed
Start date
June 12, 2014
Completion date
October 7, 2019
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer, unspecified adult solid tumor